Subscribe To
RDHL / RedHill Biopharma Ltd Announces Talicia(R) added to Medi-Cal CDL
RDHL News
By Market Watch
July 21, 2023
RedHill Biopharma's stock soars 10% after company gets U.S. funding to develop treatment for radiation sickness
RedHill Biopharma Ltd.'s stock RDHL, +1.65% soared 10% premarket after the company said it has received a further $1.7 million in U.S. government fund more_horizontal
By PennyStocks
January 28, 2023
The Impact of Market Trends on Penny Stocks Performance
Understand how market trends impact penny stocks The post The Impact of Market Trends on Penny Stocks Performance appeared first on Penny Stocks to more_horizontal
By InvestorPlace
January 27, 2023
Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?
Redhill Biopharma (NASDAQ: RDHL ) stock is rocketing higher on Friday after getting positive patent news from the U.S. Patent and Trademark Office (US more_horizontal
By PennyStocks
June 24, 2022
Hot Penny Stocks to Buy Right Now? Check These 3 Out
Can these penny stocks make gains this coming week? The post Hot Penny Stocks to Buy Right Now? more_horizontal
By Seeking Alpha
June 23, 2022
RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q1 2022 Results - Earnings Call Transcript
RedHill Biopharma Ltd. (NASDAQ:RDHL ) Q1 2022 Results Conference Call June 23, 2022 8:30 AM ET Company Participants Debbie Bechor - Business Developme more_horizontal
By PRNewsWire
June 17, 2022
RedHill Biopharma to Host First Quarter 2022 Financial Results and Operational Highlights Webcast on June 23, 2022
TEL AVIV, Israel and RALEIGH, N.C. , June 17, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. more_horizontal
By Seeking Alpha
March 17, 2022
RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q4 2021 Results - Earnings Call Transcript
RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Benzinga
March 15, 2022
RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea
RedHill Biopharma Ltd (NASDAQ: RDHL) has entered into an exclusive license agreement with Kukbo Co Ltd for oral opaganib to treat COVID-19 in Sou more_horizontal